University of Hertfordshire

From the same journal

By the same authors

View graph of relations
Original languageEnglish
Number of pages15
Pages (from-to)161-175
JournalBritish Journal of Dermatology
Journal publication date22 Jan 2018
Early online date31 Jul 2017
Publication statusPublished - 22 Jan 2018


BACKGROUND: Skin disease can affect the quality of life (QoL) of teenagers in a variety of different ways, some being unique to this age group.

OBJECTIVES: To develop and validate a dermatology-specific QoL instrument for adolescents with skin diseases.

METHODS: Qualitative semistructured interviews were conducted with adolescents with skin disease to gain in-depth understanding of how skin diseases affect their QoL. A prototype instrument based on the themes identified from content analysis of interviews was tested in several stages, using classical test theory and item response theory models to develop this new tool and conduct its psychometric evaluation.

RESULTS: Thirty-three QoL issues were identified from semistructured interviews with 50 adolescents. A questionnaire based on items derived from content analysis of interviews was subjected to Rasch analysis: factor analysis identified three domains, therefore not supporting the validity of T-QoL as a unidimensional measure. Psychometric evaluation of the final 18-item questionnaire was carried out in a cohort of 203 adolescents. Convergent validity was demonstrated by significant correlation with Skindex-Teen and Dermatology Life Quality Index (DLQI) or Children's DLQI. The T-QoL showed excellent internal consistency reliability: Cronbach's α = 0·89 for total scale score and 0·85, 0·60 and 0·74, respectively, for domains 1, 2 and 3. Test-retest reliability was high in stable volunteers. T-QoL showed sensitivity to change in two subgroups of patients who indicated change in their self-assessed disease severity.

CONCLUSIONS: Built on rich qualitative data from patients, the T-QoL is a simple and valid tool to quantify the impact of skin disease on adolescents' QoL; it could be used as an outcome measure in both clinical practice and clinical research.


© 2017 British Association of Dermatologists

ID: 14843444